Standard Chemical & Pharmaceutical Co. Ltd. - Taiwan
Figures in New Taiwan dollars.
2026 2025
Revenue NT$614,864,000 NT$527,457,000
Jan-Jan Revenue NT$614,864,000 NT$527,457,000
Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.
(END) Dow Jones Newswires
February 09, 2026 02:06 ET (07:06 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.